| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 10/16/2008 | WO2008123231A1 Novel cyclic staple-type oligonucleotide, and nf-κb decoy comprising the same |
| 10/16/2008 | WO2008123128A1 Adiponectin production enhancer |
| 10/16/2008 | WO2008123096A1 Prophylactic agent for renal failure |
| 10/16/2008 | WO2008123095A1 Prophylactic agent for heart failure |
| 10/16/2008 | WO2008123017A1 Novel diamide derivative |
| 10/16/2008 | WO2008122810A1 Phthalazinone derivatives and their use as medicament to treat cancer |
| 10/16/2008 | WO2008122667A2 Ureylene derivatives |
| 10/16/2008 | WO2008122356A1 Cardiovascular agents |
| 10/16/2008 | WO2008054208A3 Use of nutritional compositions for preventing disorders |
| 10/16/2008 | WO2008026156A3 Therapeutic compositions comprising a specific endothelin receptor antagonist and a pde5 inhibitor |
| 10/16/2008 | US20080255350 Substituted aza-indoles as inhibitors of poly(adp-ribose) polymerase (parp) |
| 10/16/2008 | US20080255240 Obesity; dietetics; hypotensive agents; antidiabetic agents; dyslipidemia; cardiovascular disorders; osteoarthritis; gall bladder disease; endometrosis; anticancer agents; vascular system disorders; apoptosis |
| 10/16/2008 | US20080255229 Reduced potential for phlebitis; treating arrhythmia |
| 10/16/2008 | US20080255222 Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases |
| 10/16/2008 | US20080255217 Administering 6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-carboxamide; percutaneous transluminal coronary angioplasty |
| 10/16/2008 | US20080255216 Diaryltriazoles as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase-1 |
| 10/16/2008 | US20080255202 Phenylthioacetic Acid Derivatives and Use Thereof |
| 10/16/2008 | US20080255191 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors |
| 10/16/2008 | US20080255183 N-[(3,5-dimethylisoxazol-4-yl)carbonyl]-3-{5-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]thiophen-2-yl}-L-alanine; treatment of solid tumors |
| 10/16/2008 | US20080255163 Compounds such as 2-piperidino-6-methyl-5-oxo-5,6-dihydro-(7H) pyrrole-[3,4-d]pyrimidine maleate (MS-818); nervous system, brain, and neurodegenerative disorders; Parkinson's, Alzheimer's, and Huntington's disease |
| 10/16/2008 | US20080255161 3-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS |
| 10/16/2008 | US20080255160 Mapk/erk kinase inhibitors |
| 10/16/2008 | US20080255153 New compounds |
| 10/16/2008 | US20080255146 Macrolide compounds comprising 18,19-epoxytricosa-8,12,14-trien-11-olide derivatives; angiogenesis inhibitors; anticarcinogenic, antimetastasis, antiinflammatory, and antitumor agents; antihypoxic agents; endothelial growth factor suppressors; retinal neovascularization, diabetic retinopathy |
| 10/16/2008 | US20080255141 Modulators of signal transduction mediated by certain native and/or mutant tyrosine kinases; antiproliferative, anticarcinogenic, antiallergen, and antiinflammatory agents; metabolic and neurodegenerative disorders |
| 10/16/2008 | US20080255134 Cardiotonic Compounds With Inhibitory Activity Against Beta-Adrenergic Receptors And Phosphodiesterase |
| 10/16/2008 | US20080255129 3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-b]indole-1-acetamide derivatives, their preparation and their application in therapeutics |
| 10/16/2008 | US20080255128 e.g. 4-[5-(Piperidine-1-carbonyl)-furan-2-ylmethyl]-2H-phthalazin-1-one; enzyme poly(ADP-ribose)polymerase (synthase)-1 or poly ADP-ribosyltransferase (PARP-1) inhibitor; anticarcinogenic agent with BRCA2 deficient phenotype; septic shock; ischemic injury; hemorrhagic shock; multiple sclerosis |
| 10/16/2008 | US20080255123 (2Z)-2-(3-butyl-4,5-dimethyl-1,3-thiazol-2(3H)-ylidene)-1-(5-chloro-2-methoxyphenyl)ethanone; antiinflammatory, analgesic agent; autoimmune diseases; neuroprotectants |
| 10/16/2008 | US20080255110 Imidazoquinoline derivatives as adenosine a3 receptor ligands |
| 10/16/2008 | US20080255108 Novel thiophene sulfoximines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 10/16/2008 | US20080255101 spiro[2H-1,2,4-benzothiadiazine-3,4'-piperidin]-1'-yloxy,7-(aminosulfonyl)-6-chloro-2',2',6',6'-tetramethyl-1,1-dioxide; antidiabetic agent; electrolyte retention; cardiovascular diseases; renovascular diseases; oxidative stress; endothelial dysfunctions; endothelial dysfunctions; cirrhosis; osteoporosis |
| 10/16/2008 | US20080255093 Compositions and methods for treating obesity and related disorders |
| 10/16/2008 | US20080255084 Combination of Organic Compounds |
| 10/16/2008 | US20080255081 Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin |
| 10/16/2008 | US20080255078 Menopausal or postmenopausal disorders, vasomotor symptoms, urogenital disorders, female sexual dysfunction, breast cancer, depression, diabetes, bone demineralization, and osteoporosis; carboxy or hydroxyalkoxyalkoxy-group-substituted phenyl at position 2 of 1,1,2-triphenylethylene compounds |
| 10/16/2008 | US20080255046 Y2 Selective Receptor Agonists for Therapeutic Interventions |
| 10/16/2008 | US20080255036 Substituted thiophenes |
| 10/16/2008 | US20080255030 Compositions and methods for the modulation of jnk proteins |
| 10/16/2008 | US20080254527 VON WILLEBRAND FACTOR (vWF) - CLEAVING PROTEASE |
| 10/16/2008 | US20080254156 Combat/reversion of spontaneous and electrical stimulus-induced ventricular fibrillation; cardiovascular disorders |
| 10/16/2008 | US20080254153 Water Dispersible Composition and Method for Preparing Same |
| 10/16/2008 | US20080254135 Resveratrol-containing compositions for general health and vitality |
| 10/16/2008 | US20080254127 Inhalation particles incorporating a combination of two or more active ingredients |
| 10/16/2008 | US20080254126 health food and drink contains the pure plant extract, is for patients with abnormality in cerebral blood flow and metabolism of brain disorder; nutraceuticals; free of proanthocyanidins |
| 10/16/2008 | US20080254109 Delivering therapeutic nucleic acid into adjacent normal heart tissue; inducing angiogenesis and collateral blood vessel formation |
| 10/16/2008 | US20080254105 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 10/16/2008 | US20080254093 Compositions and minimally invasive methods for treating dysfunction of cardiac muscle |
| 10/16/2008 | US20080254092 Promoting wound healing and tissue regeneration; inhibiting scarring; degenerative diseases |
| 10/16/2008 | US20080254043 Drug For Treating Ischemic Disease |
| 10/16/2008 | US20080254039 Prevention of Thrombus Formation and/or Stabilization |
| 10/16/2008 | US20080254037 Method of treating ischemia reperfusion injury by inhibing nkt cell activity |
| 10/16/2008 | US20080254028 Caspase-8 interacting polypeptide (Cari) for use in identifying modulators for prevention and treatment of autoimmune, inflammatory, connective tissue and liver disorders |
| 10/16/2008 | US20080254019 Therapeutic Agents and Therapeutic Methods For Treating Injured Tissue |
| 10/16/2008 | US20080254018 Solid support comprising stably conjugated neovascularizing protein for use in identifying modulators of cell proliferation |
| 10/16/2008 | US20080254011 Lactobacillus culture for increasing bile salt hydrolase (BSH) activity, lowering serum LDL-cholesterol and tumor necrosis factor alpha levels; treating cardiovascular disorders |
| 10/16/2008 | US20080254003 Differentiation of Human Embryonic Stem Cells and Cardiomyocytes and Cardiomyocyte Progenitors Derived Therefrom |
| 10/16/2008 | US20080254002 Bone Marrow Derived Oct3/4+ Stem Cells |
| 10/16/2008 | US20080253985 Sequentially or concurrently administering three active ingredients comprising an MTP inhibitor, a cholesterol absorption inhibitor, at least one of a HGM-CoA reductase inhibitor, a bile acid sequestrant, a fibric acid derivative, niacin, and a squalene sythetase inhibitor |
| 10/16/2008 | CA2683857A1 Substituted deuterium enriched thiophenes for the treatment of hypertension |
| 10/16/2008 | CA2683682A1 Phthalazinone derivatives and their use as medicament to treat cancer |
| 10/16/2008 | CA2682234A1 Compositions and methods for the treatment of heart failure |
| 10/16/2008 | CA2681746A1 Prophylactic agent for heart failure |
| 10/16/2008 | CA2681560A1 Pteridinone derivatives for use as stearoyl coa desaturase inhibitors |
| 10/16/2008 | CA2681551A1 Prophylactic agent for renal failure |
| 10/15/2008 | EP1980559A1 Cardiovascular agents |
| 10/15/2008 | EP1980265A1 Therapeutic agent |
| 10/15/2008 | EP1980258A1 Composition having effect of lowering blood pressure and/or inhibiting increase in blood pressure and food and drink containing the same |
| 10/15/2008 | EP1980252A2 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders |
| 10/15/2008 | EP1980249A2 Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser |
| 10/15/2008 | EP1980246A1 Prevention and treatment of cardiovascular pathologies with tamoxifen analogues |
| 10/15/2008 | EP1979355A1 Spiro imidazole derivatives as ppar modulators |
| 10/15/2008 | EP1979318A1 Amido compounds and their use as pharmaceuticals |
| 10/15/2008 | EP1979050A2 Treatment of peripheral vascular disease using postpartum-derived cells |
| 10/15/2008 | EP1978956A1 Complex formulation comprising amlodipine camsylate and simvastatin and method for preparation thereof |
| 10/15/2008 | EP1978950A2 Pharmaceutical sustained release compositions comrising in particular thyroid hormones |
| 10/15/2008 | EP1978941A2 Biodegradable non-ophthalmic implants and related methods |
| 10/15/2008 | EP1940445A4 Stem cell derived factors for treating pathologic conditions |
| 10/15/2008 | EP1896416B1 Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them |
| 10/15/2008 | EP1740699A4 Connexin 40 tissue specific gene mutations |
| 10/15/2008 | EP1669463B1 Casein hydrolyzate, process for producing the same and use thereof |
| 10/15/2008 | EP1660085B1 Pyridylpyrrole derivatives active as kinase inhibitors |
| 10/15/2008 | EP1537081B1 Dihydropyridine derivatives for use as human neutrophil elastase inhibitors |
| 10/15/2008 | EP1490069B1 Alpha aed and beta aed regulation of nuclear transcription, gene regulation, and/or gene expression |
| 10/15/2008 | EP1476423B1 Arylsulfonamidobenzylic compounds |
| 10/15/2008 | EP1458723B1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 10/15/2008 | EP1458722B1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors |
| 10/15/2008 | EP1444202B1 Novel metalloproteinase inhibitors |
| 10/15/2008 | EP1427409B1 Methods for treating or preventing vascular inflammation using sterol absorption inhibitor(s) |
| 10/15/2008 | EP1415663B1 Sustained release hgf hydrogel preparations |
| 10/15/2008 | EP1373257B9 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 10/15/2008 | EP1319008B1 Water soluble rapamycin esters |
| 10/15/2008 | EP1303600B1 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 10/15/2008 | EP1272517B1 Multiprotein-complexes comprising a nmda receptor and uses thereof |
| 10/15/2008 | EP1272515B1 Immunoregulator |
| 10/15/2008 | EP1200116B1 USE OF FVIIa OR A TISSUE FACTOR AGONIST FOR REGULATING GENE EXPRESSION AND CELL MIGRATION OR CHEMOTAXIS |
| 10/15/2008 | CN101287753A Conserved membrane activator of calcineurin (cmac), a novel therapeutic protein and target |
| 10/15/2008 | CN101287718A Substituted heteroaryl- and phenylsulfamoyl compounds |
| 10/15/2008 | CN101287476A Scavenger of harmful active oxygen and/or free radical in living body |
| 10/15/2008 | CN101285064A Novel conus P-superfamily toxin sequence, preparation method and uses thereof |